AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer

Clinical trial NCT01361945 · WITHDRAWN

Trial details

NCT number: NCT01361945
Sponsor: Texas Tech University Health Sciences Center, El Paso
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer HER-2 Positive Breast Cancer ER Positive Breast Cancer

Start date: 2011-07-01
Primary completion: 2012-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.